Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
China Jo-Jo Drugstores Receives Hangzhou Municipal People's Government Quality Management Excellence Award
2023-05-02 20:30
I-MAB Filed 2022 Annual Report on Form 20-F
2023-05-01 20:00
OBiO and CHINAGENE reached a strategic agreement of commercial manufacturing services for gene therapy products
2023-04-29 23:20
IMG-004 demonstrated extended half-life and durable pharmacodynamic characteristics in a Phase 1 study
2023-04-28 17:00
WuXi Biologics Releases 2022 ESG Report Detailing Its Continued Commitment to Sustainability
2023-04-28 14:43
Daewoong Pharmaceutical announces a Global License Agreement for DWP213388, a new drug candidate for autoimmune disease with Vitalli Bio
2023-04-28 08:58
Ubie signs a broad collaboration agreement with Takeda Pharmaceuticals to promote digital transformation
2023-04-27 23:00
Yuyu Pharma, Dry Eye Pipeline Mechanism of Action and Pre-clinical Results Published
2023-04-27 21:00
ASCO 2023 | Ascentage Pharma to Present Results from 4 Studies Highlighting Extended Therapeutic Potential of Lead Drug Candidates
2023-04-27 17:44
Qilian Received a Letter from Nasdaq Related to Regain Compliance
2023-04-27 05:00
Fosun Pharma Develops Innovative Artemisinin-based Antimalarial Drugs Contributing to the Efforts for A Malaria-free World Through the Belt and Road Initiative
2023-04-26 22:32
Gracell Biotechnologies to Present Updated Clinical Data on BCMA/CD19 Dual-Targeting FasTCAR-T GC012F at 2023 ASCO Annual Meeting
2023-04-26 22:15
I-Mab Announces Poster Presentation of Proprietary CD73 Antibody Uliledlimab at ASCO 2023
2023-04-26 21:16
BIORCHESTRA Scientific Founder, Chairman, and Chief Executive Officer Joins the Republic of Korea (ROK) Official State Visit to the United States
2023-04-25 20:00
Nippon Express (UK) Receives IATA CEIV Pharma Certification for Its Facility in Heathrow Airport Suburb
2023-04-25 15:00
I-Mab Announces Positive Outcome in Arbitration Relating to Agreements with Tracon
2023-04-25 13:46
Ascentage Pharma Passes GMP Compliance Audit by EU QP with Zero Deficiency, in an Achievement Signaling Global Recognition of the Company's Quality Management System
2023-04-25 08:42
I-Mab Announces First Patient Dosed in Phase 3 Registrational Study of CD47 Antibody Lemzoparlimab in MDS in China
2023-04-24 21:00
BIORCHESTRA Announces Significant Progress in Studies of BMD-001 Drug Program
2023-04-24 20:00
Four innovative drugs launched in three years, HKEX -Listed Simcere Pharmaceutical Group is on the Fast Track Toward Building an Innovation-Driven Global Pharmaceutical Company
2023-04-24 18:09
1
51
52
53
54
55
165